# Vitamin D for the prevention of diseases in children: A rebuttal to the 2024 Endocrine Society Clinical Practice Guideline

## TL;DR

This paper challenges a 2024 guideline on vitamin D, arguing for personalized approaches instead of general recommendations for children and specific groups.

## Contribution

The paper introduces data supporting precision-medicine-guided vitamin D screening and supplementation for vulnerable populations.

## Key findings

- The one-size-fits-all vitamin D recommendations are criticized as inappropriate for infants, children, and dark-skinned individuals.
- Evidence is presented for tailored vitamin D screening and supplementation based on individual needs.
- The paper advocates for personalized approaches over generalized guidelines in vitamin D prevention strategies.

## Abstract

The recent 2024 Endocrine Society Clinical Practice Guideline on Vitamin D for the prevention of diseases has become a source of controversy among medical professionals and the lay public. This Review rebuts the recommendations from this Guideline for infants, children, adolescents, pregnant women, and dark-skinned individuals. It rejects the one-size-fits-all recommendations and provides the data for precision-medicine-guided vitamin D screening and supplementation in these populations.